<DOC>
	<DOCNO>NCT00891397</DOCNO>
	<brief_summary>The purpose study assess efficacy pregabalin patient complex regional pain syndrome Type I determine whether provide clinically significant pain relief whether improves function upper limb .</brief_summary>
	<brief_title>Pregabalin Versus Placebo Add Complex Regional Pain Syndrome ( CPRS ) Upper Limb Managed Stellate Ganglion Block ( The PREGA Study )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Ganglion Cysts</mesh_term>
	<mesh_term>Synovial Cyst</mesh_term>
	<mesh_term>Complex Regional Pain Syndromes</mesh_term>
	<mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients diagnose CRPS Type I per IASP ( International Association Study Pain ) criteria state presence initiate noxious event , cause immobilization Evidence point swelling , color change , hot/cold/sweaty sensation condition account pain dysfunction upper limb Men woman age 1865 year old Women pregnant breast feeding No change treatment 4 week prior recruitment Pain score 4/10 verbal analogue scale Patients neurologic disorder unrelated CRPS Patients already pregabalin Patients renal impairment whose creatinine clearance le 60 ml/min Patients congestive heart failure also diabetic take thiazolidinedione medication like rivoglitazone Unstable psychiatric history Patients another problem equal worse pain Unstable medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>CPRS</keyword>
	<keyword>stellate ganglion block</keyword>
	<keyword>pregabalin</keyword>
	<keyword>pain</keyword>
	<keyword>Type I</keyword>
</DOC>